QT
RIGL icon

Quantbot Technologies’s Rigel Pharmaceuticals RIGL Stock Holding History

Quantbot Technologies’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,595
Closed -$68.3K – 2089
2025
Q4 		$68.3K Buy
+1,595
New +$60.1K ﹤0.01% 1478
2021
Q3 		– Sell
-120
Closed -$5K – 1830
2021
Q2 		$5K Hold
120
– – ﹤0.01% 1364
2021
Q1 		$4K Hold
120
– – ﹤0.01% 1313
2020
Q4 		$4K Buy
+120
New +$3.47K ﹤0.01% 1178

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's RIGL Position: Q1 2026 in Review

Quantbot Technologies sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 1,595 shares — an estimated $68.3K sold.

Quantbot Technologies first reported a position in RIGL in Q4 2020 and held it in 4 quarters. The position peaked at $68.3K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Quantbot Technologies reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 1,595 Rigel Pharmaceuticals shares in Q1 2026, an estimated $68.3K.
  • Quantbot Technologies first reported a position in Rigel Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Quantbot Technologies's Rigel Pharmaceuticals position peaked at $68.3K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.